Catalyst Wire Dossier Catalyst Wire Dossier

Inhaled interleukin-2

interleukin-2
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inhaled interleukin-2, covering 2014-05-22 to 2014-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer [Phase 1]

See pricing